Specialists for Gaucher disease type 2

31 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Andrew Gilman
Rare Disease / Clinical Research
Children's Oncology Group
QC-verified PI×1
Carla E M Hollak
Rare Disease / Clinical Research
Amsterdam UMC location University of Amsterdam
QC-verified 1
Eleonora L Swart
Rare Disease / Clinical Research
Amsterdam UMC location University of Amsterdam
QC-verified 1
Hennie Bikker
Rare Disease / Clinical Research
Amsterdam UMC location University of Amsterdam
QC-verified 1
Marion M Brands
Rare Disease / Clinical Research
Amsterdam UMC location University of Amsterdam
QC-verified 1
Marianne Rohrbach
Rare Disease / Clinical Research
Division of Metabolism and Children's Research Center
QC-verified 1
Matthias Gautschi
Rare Disease / Clinical Research
aediatrics and Institute of Clinical Chemistry
QC-verified 1
Marc Patterson
Rare Disease / Clinical Research
Mayo Clinic Children's Center
QC-verified 1
Bénédicte Héron
Rare Disease / Clinical Research
Reference Centre for Lysosomal Diseases
QC-verified 1
Bibiche den Hollander
Rare Disease / Clinical Research
Amsterdam UMC location University of Amsterdam
QC-verified 1
Hoang Lan Le
Rare Disease / Clinical Research
the Netherlands; Amsterdam UMC location University of Amsterdam
QC-verified 1
Sara M. Federico, MD, MD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
MEMPHIS, TN
PI×3
Helen E Heslop, MD, MD
Rare Disease / Clinical Research
Baylor College of Medicine
HOUSTON, TX
PI×6
Svetlana Kulyova, MD, Phd
Rare Disease / Clinical Research
Head of Children's Oncology Department
PI×1
Brian Kushner, MD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×10
Rosandra N Kaplan, M.D.
Rare Disease Specialist
National Cancer Institute (NCI)
Bethesda, Maryland
PI×4
Sara Federico, MD, MD
Rare Disease / Clinical Research
St. Jude Children's Research Hospital
MEMPHIS, TN
PI×4
Edward Kaye, M.D., M.D
Rare Disease / Clinical Research
Genzyme, a Sanofi Company
CAMBRIDGE, MA
PI×1
Luba Trokan
Rare Disease / Clinical Research
Idorsia Pharmaceuticals Ltd
1
Eugen Mengel
Rare Disease / Clinical Research
SphinCS GmbH
1
Barbara Schwierin
Rare Disease / Clinical Research
Idorsia Pharmaceuticals Ltd
1
Chrysoula Kosmeri
Rare Disease / Clinical Research
1
Peter Cornelisse
Rare Disease / Clinical Research
Idorsia Pharmaceuticals Ltd
1
Lung-Ji Chang
Rare Disease / Clinical Research
Shenzhen Geno-Immune Medical Institute
PI×1
Hai Yi, Ph.D
Rare Disease / Clinical Research
The General Hospital of Western Theater Command
PI×1
William Tap, M.D., MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×1
Araz Marachelian, MD
Rare Disease / Clinical Research
New Approaches to Neuroblastoma Treatment (NANT)
LOS ANGELES, CA
PI×1
Jared Weiss
Rare Disease / Clinical Research
jared_weiss@med.unc.edu
PI×1
Michelle Monje, MD, PhD
Rare Disease / Clinical Research
Stanford University
PALO ALTO, CA
PI×1
Ellen Basu, MD,PhD, MD
Rare Disease / Clinical Research
Memorial Sloan Kettering Cancer Center
NEW YORK, NY
PI×1
Gary Doolittle, MD, MD
Rare Disease / Clinical Research
University of Kansas Medical Center
OLYMPIA, WA
PI×1

More about Gaucher disease type 2